Claudia P. Oliveira

Av. Dr Arnaldo, 455, 3° Andar, #3115, 1246903
Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 111 publications

Author Correction: The dynamic spectrum of steatotic liver disease: the global perspective.

Author Correction: The dynamic spectrum of steatotic liver disease: the global perspective.

Journal: Nature reviews. Gastroenterology & hepatology
Published: August 14, 2026

The dynamic spectrum of steatotic liver disease: the global perspective.

The dynamic spectrum of steatotic liver disease: the global perspective.

Journal: Nature reviews. Gastroenterology & hepatology
Published: July 10, 2026

The dynamic spectrum of steatotic liver disease: the global perspective.

The dynamic spectrum of steatotic liver disease: the global perspective.

Journal: Nature reviews. Gastroenterology & hepatology
Published: July 10, 2026

Steatotic liver disease in Latin America: current views and perspectives.

Steatotic liver disease in Latin America: current views and perspectives.

Journal: Nature reviews. Gastroenterology & hepatology
Published: May 22, 2026

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Journal: Clinics in liver disease
Published: May 16, 2026

MRI multicomponent relaxometry for liver fibrosis, inflammation, and steatosis in nonalcoholic steatohepatitis: A prospective study.

MRI multicomponent relaxometry for liver fibrosis, inflammation, and steatosis in nonalcoholic steatohepatitis: A prospective study.

Journal: European journal of radiology
Published: March 04, 2026

Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 Diabetes.

Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 Diabetes.

Journal: JAMA network open
Published: November 06, 2025

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: November 01, 2025

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-Associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-Associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: November 01, 2025

Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: November 01, 2025

Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study.

Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study.

Journal: Hepatology (Baltimore, Md.)
Published: August 21, 2025

Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study.

Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study.

Journal: Hepatology (Baltimore, Md.)
Published: August 21, 2025
Showing 1-12 of 111

Last Updated: 09/26/2026